NEURO-JMG
The computed 12-month bankruptcy probability of NEURO-JMG is 0.1% (very low). The 2024 annual accounts show equity of €766k and a net result of €71k. Equity is growing by ~15.4% per year across the filed fiscal years. Its solvency ranks better than 76% of 255 sector peers (fiscal year 2024). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €766k |
| Net result | €71k |
| Staff (FTE) | 1.8 |
| Better than sector | 76% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 75.3% | 49.4% | |
| Net result | €71k | €50k | |
| Equity | €766k | €126k | |
| Gross operating margin | €228k | €145k | |
| Staff costs | €105k | €156k |
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | €121k |
| Net profit | €71k |
| Cash flow | €82k |
| Staff costs | €105k |
| Income taxes | €32k |
| Dividends | - |
| Total assets | €1.02M |
| Equity | €766k |
| Debt | €252k |
| of which ≤ 1y | €141k |
| of which > 1y | €111k |
| Working capital | €829k |
| Employees (FTE) | 1.8 |
| 2024 | |
|---|---|
| Current ratio | 6.89 |
| Quick ratio | 6.89 |
| Working capital ratio | 81.5% |
| Solvency | 75.3% |
| Debt / equity | 0.33 |
| Long-term debt ratio | 0.14 |
| Interest coverage | 19.41 |
| Gross margin | - |
| Net margin | - |
| ROA | 6.9% |
| ROE | 9.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.02M |
| Fixed assets | 21/28 | €47k |
| Tangible fixed assets | 22/27 | €42k |
| Financial fixed assets | 28 | €5k |
| Current assets | 29/58 | €970k |
| Amounts receivable within one year | 40/41 | €862k |
| Cash & bank | 54/58 | €109k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.02M |
| Equity | 10/15 | €766k |
| Contributions / capital | 10/11 | €12k |
| Reserves | 13 | €533k |
| Accumulated profits (losses) | 14 | €220k |
| Amounts payable | 17/49 | €252k |
| Amounts payable after one year | 17 | €111k |
| Amounts payable within one year | 42/48 | €141k |
| Trade debts payable within one year | 44 | €51k |
| Income statement | ||
| Gross operating margin | 9900 | €228k |
| Operating result | 9901 | €109k |
| Financial income | 75 | €139 |
| Financial charges | 65 | €6k |
| Result before taxes | 9903 | €103k |
| Income taxes | 67/77 | €32k |
| Net result for the period | 9904 | €71k |
| Result to be appropriated | 9905 | €71k |
| NACE primary | Activiteiten van medisch specialisten(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 03-03-2006 |
| Status | Active |
| Postal code | 1970 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22302D0339/00L005 | Flanders | 596 m² | 1 · 83 m² | 10.6 m · 3 fl. |
| 21807G0218/00A005indicative | Brussels | 249 m² | 1 · 124 m² | 20.6 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-11-2023 Change in the board of directors
Technical details
{
"events": [],
"notary": {
"name": "Matthieu VAN MOLLE",
"firm_city": null,
"firm_name": null,
"office_city": "Itter",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-11-22",
"filing_date": "2023-11-18",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2023-10-12",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0879.740.906",
"name_full": "NEURO-JMG",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Axelle GAUDIN",
"org_rep_person_name": null,
"person_role_at_subject": "geassocieerd notaris"
},
"co_filed_documents": [
"uitgifte van de akte",
"geco\u00F6rdineerde statuten"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | NEURO-JMG |